Nitric oxide-releasing mesalamine: potential utility for treatment of inflammatory bowel disease

被引：15
|
作者：
Wallace, JL [1 ]
机构：
[1] Univ Calgary, Mucosal Inflammat Res Grp, Calgary, AB T2N 4N1, Canada
来源：
DIGESTIVE AND LIVER DISEASE | 2003年 / 35卷
关键词：
aminosalicylic acid; colitis inflammation; inflammatory bowel disease;
D O I：
10.1016/S1590-8658(03)00050-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Nitric oxide can accelerate ulcer healing and exert anti-inflammatory effects. Addition of a nitric oxide-releasing moiety to mesalamine significantly boosts its anti-inflammatory activity. NO-releasing mesalamine suppresses inflammatory cytokine production and reduces leukocyte infiltration. (C) 2003 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：S35 / S40
页数：6
相关论文
共 50 条
  • [21] Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease
    Patel, Mayur M.
    Amin, Avani F.
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2013, 18 (02) : 390 - 400
  • [22] On the dynamics of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel disease
    Saijo, Fumito
    Milsom, Alexandra B.
    Bryan, Nathan S.
    Bauer, Selena M.
    Vowinkel, Thorsten
    Ivanovic, Marina
    Andry, Chris
    Granger, D. Neil
    Rodriguez, Juan
    Feelisch, Martin
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2010, 22 (02): : 155 - 167
  • [23] Technology insight:: Calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease
    Lundberg, J
    Hellström, PM
    Fagerhol, MK
    Weitzberg, E
    Roseth, AG
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (02): : 96 - 102
  • [24] Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways
    Kamalian, Aida
    Sohrabi Asl, Masoud
    Dolatshahi, Mahsa
    Afshari, Khashayar
    Shamshiri, Shiva
    Momeni Roudsari, Nazanin
    Momtaz, Saeideh
    Rahimi, Roja
    Abdollahi, Mohammad
    Abdolghaffari, Amir Hossein
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (24) : 3365 - 3400
  • [25] Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways
    Aida Kamalian
    Masoud Sohrabi Asl
    Mahsa Dolatshahi
    Khashayar Afshari
    Shiva Shamshiri
    Nazanin Momeni Roudsari
    Saeideh Momtaz
    Roja Rahimi
    Mohammad Abdollahi
    Amir Hossein Abdolghaffari
    World Journal of Gastroenterology, 2020, 26 (24) : 3365 - 3400
  • [26] Treatment of inflammatory bowel disease
    Nikolaus, S.
    Schreiber, S.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (05) : 205 - 208
  • [27] The potential therapeutic role of Lactobacillus reuteri for treatment of inflammatory bowel disease
    Wang, Huiyu
    Zhou, Chunli
    Huang, Junxiang
    Kuai, Xiaoyi
    Shao, Xinyu
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (05): : 1569 - 1583
  • [28] Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease
    Dijkstra, G
    Moshage, H
    Van Dullemen, HM
    De Jager-Krikken, A
    Tiebosch, ATMG
    Kleibeuker, JH
    Jansen, PLM
    Van Goor, H
    JOURNAL OF PATHOLOGY, 1998, 186 (04) : 416 - 421
  • [29] The Utility of FDG PET/CT in Inflammatory Bowel Disease
    Hustinx, Roland
    PET CLINICS, 2012, 7 (02) : 219 - 225
  • [30] The role and utility of faecal markers in inflammatory bowel disease
    Lehmann, Frank S.
    Burri, Emanuel
    Beglinger, Christoph
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2015, 8 (01) : 23 - 36
12345